Efficient adaptive designs for clinical trials of interventions for COVID-19 (2020)
Attributed to:
Developing efficient perpetual platform trials to study multiple treatments and multiple biomarkers
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.48550/arxiv.2005.13309
Publication URI: https://arxiv.org/abs/2005.13309
Type: Preprint